Dr Martin Payne (pictured) has taken on the role at Intelligent Fingerprinting, bringing more than 20 years’ senior Quality Assurance and Regulatory Affairs experience.
The appointment coincides with the company moving towards the commercialisation of its drug screening system, which can screen for multiple drugs of abuse in under 10 minutes by analysing chemicals in the tiny traces of sweat contained in a fingerprint.
The firm said that regulatory approvals are critical to facilitate access to key markets where drug screening is carried out. It added that with UK Government Home Office Type Approval, the company will be able to support criminal justice activities including road side screening for drug-driving, while US Food & Drug Administration (FDA) approval will enable the targeting of workplace and healthcare applications.
Dr Jerry Walker, Intelligent Fingerprinting’s chief executive, said: “I’m delighted that we have been able to bring a senior Quality Assurance and Regulatory Affairs leader on board to help support us in achieving our Home Office Type Approval and FDA approval activities. Martin is an important addition to our management team as we move towards commercialisation.”
Payne said: “At Intelligent Fingerprinting, it’s essential that we have the correct quality and regulatory processes in place across all aspects of our business, from initial R&D and manufacturing right through to deployment.
“I’m looking forward to supporting the company’s preparations for FDA and UK Government Home Office Type Approval, and making sure that we have all the right activities and processes in place to support not just our initial target market applications but also subsequent intended uses of our drug screening system.”
Last month the firm announced that it has scaled its manufacturing capacity 10-fold over the last year.
Cambridge-based firm appoints director of quality
1 min read
A Cambridge-based company, which is developing a portable fingerprint-based drug screening system, has appointed a director of quality to head up the firm’s Quality Assurance and Regulatory Affairs activities.
